Repligen Corporation is a global life sciences company that develops and commercializes bioprocessing technologies and systems for biological drug manufacturing. Products span four franchises: Filtration (XCell ATF, KrosFlo TFF, hollow fiber filters), Chromatography (OPUS columns, BioSMB systems), Process Analytics (FlowVPX, SciLog), and Proteins (Protein A ligands). Customers include global biopharmaceutical companies, contract development and manufacturing organizations, and life science integrators producing mAbs, RNA therapeutics, vaccines, and cell and gene therapies.
Q2 FY2026 — expected 2026-09-18
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2026-02-26 | 2025-12-31 | 0001193125-26-076528 | EDGAR | 62K words |
| 2025-03-14 | 2024-12-31 | 0000950170-25-038999 | EDGAR | — |
| 2024-02-22 | 2023-12-31 | 0000950170-24-018809 | EDGAR | — |
| 2023-02-22 | 2022-12-31 | 0000950170-23-003793 | EDGAR | — |
| 2022-02-17 | 2021-12-31 | 0000950170-22-001430 | EDGAR | — |
| 2021-02-24 | 2020-12-31 | 0001193125-21-054675 | EDGAR | — |
| 2020-02-26 | 2019-12-31 | 0001193125-20-050136 | EDGAR | — |
| 2019-03-01 | 2018-12-31 | 0001193125-19-060645 | EDGAR | — |
| 2018-02-22 | 2017-12-31 | 0001193125-18-054262 | EDGAR | — |
| 2017-02-23 | 2016-12-31 | 0001193125-17-054220 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-11-04 | 2025-09-30 | 0001193125-25-264666 | EDGAR | 26K words |
| 2025-08-07 | 2025-06-30 | 0000950170-25-105166 | EDGAR | — |
| 2025-04-29 | 2025-03-31 | 0000950170-25-060156 | EDGAR | — |
| 2024-11-18 | 2024-09-30 | 0000950170-24-127846 | EDGAR | — |
| 2024-07-30 | 2024-06-30 | 0000950170-24-087981 | EDGAR | — |
| 2024-05-01 | 2024-03-31 | 0000950170-24-051310 | EDGAR | — |
| 2023-10-31 | 2023-09-30 | 0000950170-23-056871 | EDGAR | — |
| 2023-08-02 | 2023-06-30 | 0000950170-23-037204 | EDGAR | — |
| 2023-05-02 | 2023-03-31 | 0000950170-23-016729 | EDGAR | — |
| 2022-11-01 | 2022-09-30 | 0000950170-22-020864 | EDGAR | — |
| 2022-08-02 | 2022-06-30 | 0000950170-22-013883 | EDGAR | — |
| 2022-04-27 | 2022-03-31 | 0000950170-22-006373 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2026-02-24 | 0001193125-26-065246 | EDGAR | 9K words |
| 2026-01-06 | 0001193125-26-003467 | EDGAR | — |
| 2025-10-28 | 0001193125-25-252385 | EDGAR | — |
| 2025-09-02 | 0001193125-25-193481 | EDGAR | — |
| 2025-07-29 | 0000950170-25-099389 | EDGAR | — |
| 2025-05-15 | 0000950170-25-072664 | EDGAR | — |
| 2025-04-29 | 0000950170-25-059569 | EDGAR | — |
| 2025-02-20 | 0000950170-25-023742 | EDGAR | — |
| 2024-11-12 | 0001193125-24-255167 | EDGAR | — |
| 2024-09-18 | 0001193125-24-221406 | EDGAR | — |
286 total filings indexed. 254 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0000730272 |
| Ticker | RGEN |
| Exchange | Nasdaq |
| SIC | 2836: Biological Products, (No Diagnostic Substances) |
| Incorporated | DE |
| Headquarters | Waltham, Massachusetts |
| Website | https://www.repligen.com |
| Listed | 1986-04-29 |
This is the free public profile. For structured JSON with full provenance chain, use the API:
JSON Profile Stock Quote AI Readiness Report